Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|87|3|167-172

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.3, 2014-07, pp. : 167-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy

By  

Oncology, Vol. 82, Iss. 5, 2012-04 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis

By  

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 175-183

Karger

Access to resources Recommend Favorite

Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-06 ,pp. : 577-581

Karger

Access to resources Recommend Favorite

Prolonged Survival of Patients with Metastatic Colorectal Cancer following First-Line Oxaliplatin-Based Chemotherapy with Molecular Targeting Agents and Curative Surgery

By  

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 167-174

Karger

Access to resources Recommend Favorite

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

By  

Oncology, Vol. 90, Iss. 1, 2016-0 ,pp. : 36-42

Karger

Access to resources Recommend Favorite